Pataccini, G., Vanzulli, S., Lanari, C. L. M., & Giulianelli, S. J. (2021). CDK4/6 inhibitors and antiprogestins: Therapeutic combination in breast cancer experimental models with high levels of progesterone receptor isoform A. Web
Citación estilo ChicagoPataccini, Gabriela, Silvia Vanzulli, Claudia Lee Malvina Lanari, and Sebastian Jesus Giulianelli. CDK4/6 Inhibitors and Antiprogestins: Therapeutic Combination in Breast Cancer Experimental Models With High Levels of Progesterone Receptor Isoform A. 2021.
Cita MLAPataccini, Gabriela, Silvia Vanzulli, Claudia Lee Malvina Lanari, and Sebastian Jesus Giulianelli. CDK4/6 Inhibitors and Antiprogestins: Therapeutic Combination in Breast Cancer Experimental Models With High Levels of Progesterone Receptor Isoform A. 2021.